S. 1702

119th Congress

In Committee

Access to Prescription Digital Therapeutics Act of 2025

Sponsored byRepublican:Sen. Capito, Shelley Moore [R-WV]WV· Introduced 8 May 2025
Open on Congress.gov

4

Cosponsors

2

Actions

0

Amendments

1

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Read twice and referred to the Committee on Finance.

8 May 2025·1 year ago

Summary

Introduced in Senate · Updated 6 June 2025

Access to Prescription Digital Therapeutics Act of 2025

This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.

Timeline

2 actions

  1. Read twice and referred to the Committee on Finance.

    8 May 2025 · IntroReferral

  2. Introduced in Senate

    8 May 2025 · IntroReferral

Sponsorship

4 cosponsors

Sponsor

Republican:Sen. Capito, Shelley Moore [R-WV]WV

Cosponsors

  • Democrat250%
  • Republican250%

Classification

Policy area

Health

Committees

1

  • Finance Committee

    Senate · Standing

    • Referred To8 May 2025
    • Referred To8 May 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 1 on 8 May 2025 to 4 on 16 June 2026.

Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.